.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Deloitte
QuintilesIMS
Harvard Business School
Covington
Federal Trade Commission
Johnson and Johnson
Citi
Novartis
Julphar

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,005,078

« Back to Dashboard

Details for Patent: 4,005,078

Title: Dithioketal derivatives of 13-polycarbonalkylgon-4-en-3-ones
Abstract:Novel 3-thioketals of 13-polycarbonalkyl-17-ethynyl-17-hydroxygon-4-ene and 13-polycarbonalkyl-17-chlorethynyl-17-hydroxygon-4-ene, with improved separation of activities, i.e. maximizing progestational and minimizing androgenic action, are prepared from the corresponding 3-carbonyl compounds by treatment with dithioethylene ketal in the presence of an acid catalyst.
Inventor(s): Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA)
Assignee: Smith; Herchel (Bryn Mawr, PA)
Filing Date:Jun 29, 1966
Application Number:04/561,365
Claims:1. The composition of matter selected from the group consisting of 17-ethynyl-17.beta.-hydroxy-gon-4-en-3-thioketal having an alkyl group containing 2 to 4 carbons at the 13-position, 17-chloroethynyl-17.beta.-hydroxy-gon-4-en-3-thioketal having an alkyl group containing 2 to 4 carbons at the 13-position, and the acetate esters thereof.

2. A compound of claim 1 which is 13.beta.-ethyl-17.alpha.-ethynyl-3,3-ethylenedithiogon-4-en-17.beta.-ol.

3. A compound of claim 1 which is 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-acetoxy-3,3-ethylenedithiogon-4- ene.

4. A compound of claim 1 which is 13.beta.-ethyl-17.alpha.-chloro-ethyl-17.beta.-hydroxy-3,3-ethylenedithiog on-4-ene.

5. A compound of claim 1 which is 13.beta.-ethyl-17.alpha.-chloro-ethynyl-17.beta.-acetoxy-3,3-ethylenedithi ogon-4-ene.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Medtronic
Mallinckrodt
Johnson and Johnson
Moodys
Argus Health
Merck
Express Scripts
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot